Skip to content

EBITDA at other companies

Embecta Corp. logo
Embecta Corp.EMBC
$45.2M-37.1%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-$2.36M-395%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$4.84M+23.0%
UFP Technologies logo
UFP TechnologiesUFPT
$28.27M+1.8%
Baxter International logo
Baxter InternationalBAX
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Calculated from KORU Medical Systems’s reported figures.

$864.9Kebit+
$197.5KDepreciation Depletion & Amortization
=-$667.39K

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's EBITDA?
KORU Medical Systems (KRMD) reported EBITDA of -$667.39K in Q1 2026.
How has KORU Medical Systems's EBITDA changed year-over-year?
KORU Medical Systems's EBITDA increased by 35.1% year-over-year, from -$1.03M to -$667.39K.
What is the long-term trend for KORU Medical Systems's EBITDA?
Over 4 years (2021 to 2025), KORU Medical Systems's EBITDA has grown at a -24.3% compound annual growth rate (CAGR), from -$6.57M to -$2.16M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.